Skip to main
FBRX

FBRX Earnings Dates & Reports

FBRX Most Recent Earnings

Report Date
Period EndingQ2 2026
Est. EPS-$1.01
Actual EPS-$0.97
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FBRX Earnings per Share (EPS) History

Signup for full access
Browse free

FBRX Latest Earnings

The value each FBRX share was expected to gain vs. the value each share gained.

FBRX reported its most recent earnings on for Q2 2026, posting earnings per share (EPS) of -$0.97. This exceeded analysts' expectations of -$1.01 by 3.96%, marking a Beat.

For comparison, Forte Biosciences Inc reported EPS of -$0.96 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$1.05.

FBRX Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2026
-$1.05
Q2 2026
-$1.01-$0.97-3.96%
Q1 2026
-$1.11-$1.24+11.71%
Q4 2025
-$1.26-$1.45+15.08%
Q3 2025
-$1.06-$0.99-6.60%
View all

FBRX Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Forte Biosciences Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

FBRX Earnings FAQs

FBRX last reported earnings on Aug 12, 2026 for Q2 2026, posting an EPS of -$0.97, which Beat the estimate of -$1.01 by 3.96%.

For Q2 2026, FBRX reported an EPS of -$0.97, exceeding analysts' estimate of -$1.01 by 3.96%.

For Q2 2026, FBRX Beat expectations with an actual EPS of -$0.97 vs. an estimated EPS of -$1.01.

Following the last earnings report on Aug 12, 2026, FBRX's stock price moved — from — to —.

The next FBRX earnings call is scheduled for Nov. 13, 2026, where executives will discuss financial results and outlook.

Forte Biosciences Inc (FBRX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.